CIK 0001863127
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831476348
- Phone
- +1 619-728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Executive Officer sold 2,000 shares at $16.13 ($32,252)
- 4 Planned sale Chief Operating Officer sold 4,400 shares at an average $16.07 ($70,729)
- 4 Open-market sale Chief Executive Officer sold 4,327 shares at an average $16.07 ($69,556)
- 4 Open-market sale Chief Operating Officer sold 13,581 shares at an average $16.03 ($217,763)
- 4 Open-market sale Chief Executive Officer sold 5,912 shares at $16.00 ($94,592)
- 4 Open-market sale Chief Executive Officer sold 19,236 shares at $16.00 ($307,776)
- 4 Open-market sale Chief Operating Officer sold 22,727 shares at $16.00 ($363,632)
- 4 Grant or award Chief Executive Officer acquired 1,808 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 1,893 shares (grant or award)
- 4 Gift Chief Development Officer gave 8,442 shares (gift)
- 4 Open-market sale 10% owner sold 265,568 shares at an average $13.17 ($3,498,611)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 7 of 11 · 203 filings